RETRACTED ARTICLE: A novel polymorphism of the GP78 gene is associated with coronary artery disease in Han population in China

[1] Zee RY(2006)Genetic variants of arachidonate 5-lipoxygenase-activating protein, and risk of incident myocardial infarction and ischemic stroke: a nested case–control approach Stroke 37 2007-2011

[2] Cheng S(1994)Genetic susceptibility to death from coronary heart disease in a study of twins N Engl J Med 330 1041-1046

[3] Erlich HA(2005)Ecacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90056 participants in 14 randomised trials of statins Lancet 366 1267-1278

[4] Lindpaintner K(2003)Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis Br Med J 326 1423-687

[5] Rifai N(2000)Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations Lancet 355 675-1378

[6] Marenberg ME(2007)Cholesterol fractions and apolipoproteins as risk factors for heart disease mortality in older men Arch Intern Med 167 1373-430

[7] Risch N(1990)Regulation of the mevalonate pathway Nature 343 425-621

[8] Berkman LF(2008)Feedback regulation of cholesterol synthesis: sterol-accelerated ubiquitination and degradation of HMG CoA reductase Cell Res 18 609-189

[9] Floderus B(2005)Insig-mediated degradation of HMG CoA reductase stimulated by lanosterol, an intermediate in the synthesis of cholesterol Cell Metab 1 179-840

[10] De Faire U(2005)Gp78, a membrane-anchored ubiquitin ligase, associates with Insig-1 and couples sterol-regulated ubiquitination to degradation of HMG CoA reductase Mol Cell 19 829-225

[1] Zee RY(2006)Genetic variants of arachidonate 5-lipoxygenase-activating protein, and risk of incident myocardial infarction and ischemic stroke: a nested case–control approach Stroke 37 2007-2011

[2] Cheng S(1994)Genetic susceptibility to death from coronary heart disease in a study of twins N Engl J Med 330 1041-1046

[3] Erlich HA(2005)Ecacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90056 participants in 14 randomised trials of statins Lancet 366 1267-1278

[4] Lindpaintner K(2003)Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis Br Med J 326 1423-687

[5] Rifai N(2000)Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations Lancet 355 675-1378

[6] Marenberg ME(2007)Cholesterol fractions and apolipoproteins as risk factors for heart disease mortality in older men Arch Intern Med 167 1373-430

[7] Risch N(1990)Regulation of the mevalonate pathway Nature 343 425-621

[8] Berkman LF(2008)Feedback regulation of cholesterol synthesis: sterol-accelerated ubiquitination and degradation of HMG CoA reductase Cell Res 18 609-189

[9] Floderus B(2005)Insig-mediated degradation of HMG CoA reductase stimulated by lanosterol, an intermediate in the synthesis of cholesterol Cell Metab 1 179-840

[10] De Faire U(2005)Gp78, a membrane-anchored ubiquitin ligase, associates with Insig-1 and couples sterol-regulated ubiquitination to degradation of HMG CoA reductase Mol Cell 19 829-225